MONDAY, Nov. 19, 2018 — The risk for sexual transmission of HIV is negligible when an HIV-positive sex partner adheres to antiretroviral therapy and maintains viral suppression, according to research published in the November issue of CMAJ, the journal of the Canadian Medical Association.
Jennifer LeMessurier, M.D., M.P.H., from the University of Ottawa in Canada, and colleagues conducted an overview and systematic review update to examine the risk for sexual transmission of HIV between serodiscordant partners. HIV incidence was calculated per 100 person-years in 12 reviews.
The researchers found that based on one review, HIV transmission risk for condom use without antiretroviral therapy was estimated at 1.14 transmissions/100 person-years (95 percent confidence interval, 0.56 to 2.04). There were 23 transmissions over 10,511 person-years with antiretroviral therapy (0.22 transmissions/100 person-years; 95 percent confidence interval, 0.14 to 0.33) in 11 studies. With antiretroviral therapy and a viral load of less than 200 copies/mL across consecutive measurements four to six months apart, there were no transmissions (0.00 transmissions/100 person-years, regardless of condom use; 95 percent confidence interval, 0.00 to 0.28).
“These findings will support individual patient and clinician decision-making, and will have implications for public health case management and contact tracing,” the authors write. “The Department of Justice Canada used these findings to inform their 2017 report on the justice system’s response to HIV nondisclosure, and they may inform the responses of other justice systems.”
© 2018 HealthDay. All rights reserved.
Posted: November 2018
- AHA: 12-Year-Old Heart Defect Survivor Inspires NFL Player’s Foundation
- Breast cancer patients who take heart drug with trastuzumab have less heart damage
- Providing aid to those humans – and animals – affected by the California fires
- Even without proof, CBD is finding a niche as a cure-all
- Drawing leads to better memory than writing
- Researchers report novel findings on plant hormone
- A Tale of Two Labels
- Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
- A 14-year-old explains what it’s like to get a new heart
- Team Players Honored with 2018 Baton Awards
- Global report highlights how the changing world is affecting children’s physical activity levels
- Genes play a role in physical activity and sleep
- DDT in Alaskan fish shown to increase risk of cancer
- Laws to curb use of cell phones have greatly reduced fatalities for motorcyclists
- Argenx Provides Detailed Data from Phase 2 Clinical Trial of Efgartigimod in Immune Thrombocytopenia and Phase 1/2 Clinical Trial of Cusatuzumab in Acute Myeloid Leukemia
- University of Maryland doctors treat first breast cancer patients with GammaPod radiotherapy
- The heartbeat seat: Demoing new well-being technologies in a car
- Leading Cancer Researcher to Direct Herbert Irving Comprehensive Cancer Center
- Study compares pain-related diagnoses in First Nations and non-First Nations children, youth
- Experts address sleep disorders following traumatic brain injury